Phleomycin
(Synonyms: 腐草霉素,Zeocin) 目录号 : GC14081Phleomycin是一种糖肽类抗生素,是一种DNA链断裂(DNA-SB)诱导剂,可用于筛选基因工程细胞。
Cas No.:11006-33-0
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
Cell experiment [1]: | |
Cell lines | HeLa cells |
Preparation Method | Cells (6×104 per well) were allowed to attach in 24-well plates for 1 day before adding Phleomycin and cultures were measured at 0, 6 , 12, 18, 24h and 100, 200, 300, 400μg/mL of Phleomycin with a hemacytometer. The cytotoxic effects of Phleomycin on HeLa cells was determined by a viable cell count and MTT assay. |
Reaction Conditions | 100, 200, 300, 400μg/mL; 0-24h |
Applications | Phleomycin inhibits HeLa cells proliferation and induces cytotoxicity in a dose-dependent and time-dependent manner. |
References: |
Phleomycin is a glycopeptide antibiotic and a DNA strand break (DNA-SB) inducer that can be used to select genetically-engineered cells[1]. Phleomycin is a molecule found in Streptomyces, and similar to bleomycin, can bind to and insert into DNA, disrupting the integrity of the double helix structure[2]. Phleomycin has a mutagenic effect on resistant Streptococcus strains[3].
In vitro, treatment of HeLa cells with Phleomycin (100-400μg/mL) for 0-24h inhibited cell proliferation in a time- and dose-dependent manner, induced cytotoxicity, induced the initial release of cytochrome c, downregulation of Bcl-XL, ENDOG, DAXX, and MDM2, and upregulation of CASP and BID[4]. Treatment of Nannochloropsis oceanica cells with Phleomycin (0.2μg/mL) for 48h caused random double-strand breaks in the DNA of the algal cells and increased the transformation efficiency of the active hygromycin B resistance gene (aph7)[5]. Phleomycin (0-200ng/mL) treatment of mouse embryonic fibroblasts (MEFs) from different mutants for 48h significantly reduced the survival rate of MEFs lacking XRCC4, DNA-Ligase IV or Xlf, but had no significant effect on MEFs from PAXX mutants and wild-type MEFs[6].
References:
[1] Ma X, Pan K, Zhang L, et al. Genetic transformation of Nannochloropsis oculata with a bacterial phleomycin resistance gene as dominant selective marker[J]. Journal of Ocean University of China, 2016, 15: 351-356.
[2] Stokowa-Sołtys K, Dzyhovskyi V, Wieczorek R, et al. Phleomycin complex–Coordination mode and in vitro cleavage of DNA[J]. Journal of inorganic biochemistry, 2019, 195: 71-82.
[3] Van Peer A F, De Bekker C, Vinck A, et al. Phleomycin increases transformation efficiency and promotes single integrations in Schizophyllum commune[J]. Applied and Environmental Microbiology, 2009, 75(5): 1243-1247.
[4] Hwang J, Kim Y Y, Huh S, et al. The Time‐Dependent Serial Gene Response to Zeocin Treatment Involves Caspase‐Dependent Apoptosis in HeLa Cells[J]. Microbiology and immunology, 2005, 49(4): 331-342.
[5] Zhang Z, Guo L, Liu H, et al. Zeocin treatment significantly elevated transformation efficiency of Nannochloropsis oceanica[J]. Journal of Applied Phycology, 2022, 34(3): 1587-1594.
[6] Abramowski V, Etienne O, Elsaid R, et al. PAXX and Xlf interplay revealed by impaired CNS development and immunodeficiency of double KO mice[J]. Cell Death & Differentiation, 2018, 25(2): 444-452.
Phleomycin是一种糖肽类抗生素,是一种DNA链断裂(DNA-SB)诱导剂,可用于筛选基因工程细胞[1]。Phleomycin是在链霉菌中发现的,与博来霉素 (Bleomycin)类似,它能够结合并插入DNA,破坏双螺旋结构的完整性[2]。Phleomycin对抗性链球菌菌株具有诱变作用[3]。
在体外,Phleomycin(100-400μg/mL)处理HeLa细胞0-24h,以时间和剂量依赖性方式抑制了细胞增殖,诱导了细胞毒性,诱导了细胞色素c的初始释放、Bcl-XL、ENDOG、DAXX和MDM2的下调以及CASP和BID的上调[4]。Phleomycin(0.2μg/mL)处理微拟球藻(Nannochloropsis oceanica)细胞48h,引起了藻细胞DNA的随机双链断裂,提高了活性潮霉素B抗性基因(aph7)的转化效率[5]。Phleomycin(0-200ng/mL)处理来自不同突变体的鼠胚胎成纤维细胞(MEFs)48h,显著降低了缺乏XRCC4、DNA-Ligase IV或Xlf的MEFs的存活率,但对来自PAXX突变体的MEFs和野生型MEFs无显著影响[6]。
Cas No. | 11006-33-0 | SDF | |
别名 | 腐草霉素,Zeocin | ||
化学名 | (2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-(2-(6-amino-2-(3-amino-1-((2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-((5-((1-((2-(4-((4-guanidinobutyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-o | ||
Canonical SMILES | NC(CNC(CC(N)=O)C1=NC(N)=C(C(C(NC(C(NC(C(C(C)C(NC(C(NCCC2=NC(C3=NC(C(NCCCCNC(N)=N)=O)=CS3)CS2)=O)C(O)C)=O)O)C)=O)C(O[C@H]4[C@]([H])([C@H]([C@@H]([C@@H](O4)CO)O)O)O[C@H]5O[C@@H]([C@H]([C@@H]([C@@H]5O)OC(N)=O)O)CO)C6=CNC=N6)=O)=N1)C)C(N)=O.[Cu+2].Cl | ||
分子式 | C55H85N20O21S2Cu • HCl | 分子量 | 1526.5 |
溶解度 | ≤10mg/ml in PBS, pH 7.2 | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.6551 mL | 3.2755 mL | 6.5509 mL |
5 mM | 0.131 mL | 0.6551 mL | 1.3102 mL |
10 mM | 0.0655 mL | 0.3275 mL | 0.6551 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。